type 2 diabetes

FDA approves injection for type 2 diabetes

On July 28, the Food and Drug Administration (FDA) approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control, along with diet and exercise, in adults with type…

FDA approves new diabetes treatment

In late September 2019, the U.S. Food and Drug Administration (FDA) approved a new oral treatment for type 2 diabetes. Novo Nordisk’s Rybelsus (semaglutide) helps improve adult patients’…

FDA approves new drug for type 2 diabetes

On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with…
serotonin reuptake inhibitor diabetes

Prolonged SRI use and risk of diabetes

Prolonged use of serotonin reuptake inhibitors (SRIs) in children and adolescents may increase the risk of developing type 2 diabetes, according to a study in JAMA Pediatrics. (more…)

Six more hot drugs for today and beyond

These six drug profiles, along with the six in the March issue of American Nurse Today, bring you up to date on significant advances in drug therapy.
type 2 diabetes

Take Note – July 2007

On-line video-based course on emergency preparedness   The need for better coordination between governmental agencies and hospitals became apparent after 9/11 and again after Hurricane Katrina. To fill this…
flu shot kids note

Take Note – October 2006

CDC recommends annual flu shots for children ages 2 to 4 For the first time, the Centers for Disease Control and Prevention (CDC) is endorsing yearly flu shots…

Type 2 diabetes in Asian Americans

Follow evidence-based guidelines to target individual care needs. Takeaways: Using body mass index as an indicator for type 2 diabetes is now considered inaccurate, especially among Asians, who…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.